We report herein two cases of reactive capillary hemangiomas during the clinical trials of SHR-1210, a humanized anti-PD-1 IgG4 antibody.A female in her 20s with a history of stage IVa Hodgkin's ly...
No takes yet. Share an insight, caveat, or question.
Teng et al. (2019) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: